Doceree has unveiled Semmelweis, a proprietary artificial intelligence reasoning and orchestration model built exclusively for pharmaceutical commercialisation and marketing.
The model serves as the intelligence layer powering Daily Command, Doceree’s newly launched commercial operating system designed to manage the full pharma marketing lifecycle.
Unlike general-purpose AI models trained on open web data, Semmelweis is grounded in clinical context, drawing on treatment pathways, care behaviour, and prescribing intent.
Doceree refers to these clinical data inputs as Clinical Intent Signals, giving the model a specialised foundation that general AI platforms cannot readily replicate.
Harshit Jain, MD, founder and global CEO of Doceree, said the company built Semmelweis to identify prescribing signals early while operating within industry compliance requirements.
Semmelweis also powers Doceree’s broader product suite, including its Clinical Intent Suite, RepTwin field-agent tool, Co-pay.com, and the Doceree Marketplace.
Rather than optimising for impressions or claims, the model is designed specifically to drive filled and refilled prescriptions as its core performance measure.
Daily Command orchestrates the entire commercialisation journey from physician awareness to filled prescription, across every channel and format, including generative AI environments.
Doceree also launched generative AI Connectors, starting with native integrations to OpenAI’s ChatGPT and Anthropic’s Claude, bringing Semmelweis intelligence into platforms where clinicians and patients increasingly ask their first questions about conditions or therapies.
Kamya Elawadhi, co-founder and president of Doceree, described the model as something that operates invisibly beneath the company’s client-facing products and tools.
“Our clients never see the model, they see what it makes possible,” Elawadhi said, emphasising the seamless nature of how Semmelweis integrates across every Doceree product.
“And because one model runs beneath every Doceree product, that standard follows our clients everywhere they work with us,” Elawadhi added, underscoring the consistency this unified approach delivers.
The model’s name pays tribute to Ignaz Semmelweis, the 1840s Hungarian physician who discovered that hand-washing among doctors dramatically reduced deaths among mothers in maternity wards.
Doceree has noted that “the defensibility has never resided in the base model — frontier weights are licensed, and they commoditize by the quarter,” signalling where the company believes its competitive edge truly lies.
By embedding clinical intelligence directly into its entire product ecosystem, Doceree is positioning itself as a specialist platform at a time when AI adoption across the pharmaceutical sector is accelerating rapidly.